Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablet Under Fasting Conditions

Condition:   Healthy Subjects Interventions:   Drug: Torrent's Olmesartan Medoxomil Tablets 40 mg;   Drug: Daiichi Sankyo Inc's Benicar Tablets 40 mg Sponsor:   Torrent Pharmaceuticals Limited Completed

Source: ClinicalTrials.gov - October 23, 2017 Category: Research Source Type: clinical trials